Navigation Links
Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
Date:2/26/2013

ated with Qsymia for one year experienced significant weight loss and clinically meaningful improvements in their underlying cardiovascular risk factors," said Suzanne Oparil , M.D., Director of the Vascular Biology and Hypertension Program, University of Alabama at Birmingham, and an investigator in the study.

At Vuvus, Qsymia is in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. Qsymia is approved in the U.S. and is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol.

Achillion Pharmaceuticals announces pricing of public offering of common stock

Achillion Pharmaceuticals Inc. is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious diseases and is focused on solutions for the most challenging problems in infectious disease including HCV and resistant bacterial infections. The company announced today the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $8.40 per share. The net proceeds to Achillion from the sale of the shares, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $118.5 million. The free report on Achillion Pharmaceuticals Inc. can be downloaded by signing up now at

http://www.StockCall.com/ACHN022613.pdf

The offering is expected to close on February 27, 2013, subject to customary closing conditions. Citigroup and Leerink Swann LLC are acting as joint book-running managers, and JMP Securities LLC, '/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
2. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
3. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Titles Until the End of December at Chemical Publishing Company
4. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
5. CMC Biologics Highlights Technical Acumen at Upcoming Conferences
6. Neurovascular/Interventional Neurology Market: Global Trends & Competitive Analysis - 2017
7. Corporate Financial Planning Experts Gather at IE – Innovation Enterprise’s Financial Planning & Analysis for Pharma & Biotech Summit
8. Foot & Ankle Devices Market (2012 – 2017) By Product Type (External Fixation, Internal Fixation, Joint Replacement, Prosthesis, Bracing) - Global Trends & Competitive Analysis
9. Japan Bioinformatics Announces the Release of their Simbiot® Time Course Analysis ‘How-To’ Guide
10. Rigaku Announces Method for Quantitative Elemental Analysis of Low-Alloy Steel with the Rigaku ZSX Primus III+ WDXRF Spectrometer
11. Regenerative Medicine and Stem Cells Market Deals Analysis in New Research Report at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Peter Walter was chosen ... for his pioneering work on how proteins are transported ... a regulatory mechanism that cells use to handle stress ... is a professor of biochemistry at the University of ... treating a range of human diseases related to defective ...
(Date:3/27/2015)... , March 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a commercial focus on China ... 12 months ended December 31, 2014.  ... or ($0.05) per share, for the three months ended ...
(Date:3/26/2015)... PRC Clinical, a Silicon-Valley based ... and executive appointments effective immediately. , Mike Catelani will ... member of the Board of Directors. Daniel Head is ... Dowden will assume the position of Senior Director of ... Officer (COO), has been appointed to the position of ...
(Date:3/26/2015)... , March 26, 2015  BioNano Genomics, Inc., the ... Terry Salyer as chief commercial officer. Salyer has ... worldwide sales teams in life sciences. At BioNano, Salyer ... System, a genome-mapping platform to assemble a comprehensive view ... variations. To date, 32 institutions located in ...
Breaking Biology Technology:German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3
... Calif., Jan. 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... consolidated,its operations, with a primary focus on the ... restructuring includes a workforce reduction,of 52 employees, representing ... addition, Alexza and Endo Pharmaceuticals, Inc. have agreed ...
... Jan. 29 Repligen Corporation (Nasdaq: RGEN ... Executive Officer, Walter C. Herlihy, Ph.D., will host a ... at 10:00 a.m. EST, to report third quarter fiscal ... update of the Company.This call is being webcast by ...
... Founder of Leader In LESS Instrumentation Is Selected for ... Summit FRAMINGHAM, Mass., Jan. 29 Cambridge Endo, a ... Port Access Laparoscopic Surgery or SPA) market, is pleased ... was among the industry leaders selected to be on ...
Cached Biology Technology:Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results 2Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results 3Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009 2
(Date:3/5/2015)... , March 5, 2015 In Brazil ... of companies already using these solutions and 42 percent planning ... the latter, approximately 25 percent of the companies will be ... While the majority of companies in the region are currently ... the hybrid model will command significant attention in the coming ...
(Date:3/2/2015)... Calif. , March 2, 2015 ... leading developer of human interface solutions, today announced ... that is designed to enable rapid and secure ... ID™ module for gaming is a turnkey solution ... the ability to quickly integrate fingerprint ID solutions ...
(Date:2/25/2015)... ROCK, Ark. , Feb. 25, 2015 /PRNewswire/ ... software and billing in the Health and Fitness ... as well as to MYiCLUBonline.  The latest upgrade ... and the inclusion of cardless check-in via Identity ... for the first time through interactive displays at ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
... be glad about madder: The climbing plant has the potential to ... the City College of New York have discovered that the madder ... organic dye that can be turned into a highly effective, natural ... times to create dye for fabrics. The discovery ...
...  IDenta Corp. (OTC Pink: IDTA) CEO Yaacov Shoham today ... publish in an article describing in much detail IDenta Corp. ... by Ellen Groniger Senior Business Editor ... be seen at the following link: http://www.yousendit.com/download/WUJZY051UzdEa1ZqQTlVag ...
... sequenced DNA molecules without the need for the standard ... approach, the researchers generated sequence data using considerably less ... to less than one nanogram of DNA; 500 times ... Libraries are collections of DNA fragments derived from genomic ...
Cached Biology News:Rice cultivates green batteries from plant 2Rice cultivates green batteries from plant 3International Drug & Explosives Detection Company IDenta Corp. Article to be Published by Zillion International 2No need to prepare 2
...
D.R. Harper and C. Grose (1994) • Includes: virus structure & replication, fundamental virology, immunology and pathogenesis, vaccines and antiviral drugs, novel diagnostic techniques, cloning a...
... This book is unique in that ... techniques currently used in the diagnosis ... virus-specific antibodies and clinical virus isolates. ... blotting and hybridization procedures, PCR for ...
...
Biology Products: